Abstract
Astrocytes are the most populous cell type of the human central nervous system and are essential for physiological brain function. Increasing evidence suggests multiple roles for astrocytes in Parkinson’s disease, nudging a shift in the research focus, which historically pivoted around ventral midbrain dopaminergic neurons (vmDANs). Studying human astrocytes and other cell types in vivo remains challenging. However, in vitro-reprogrammed human stem cell-based models provide a promising alternative. Here, we describe a novel protocol for astrocyte differentiation from human stem cell-derived vmDAN-generating progenitors. This protocol simulates the regionalization, gliogenic switch, radial migration and final differentiation that occur in the developing human brain. We characterized the morphological, molecular and functional features of these ventral midbrain patterned astrocytes with a broad palette of techniques and identified novel candidate midbrain-astrocyte specific markers. In addition, we developed a new pipeline for calcium imaging data analysis called deCLUTTER2+ (deconvolution of Ca2+ fluorescent patterns) that can be used to discover spontaneous or cue-dependent patterns of Ca2+ transients. Altogether, our protocol enables the characterization of the functional properties of human ventral midbrain patterned astrocytes under physiological conditions and in disease.
Original language | English |
---|---|
Article number | dmm049980 |
Journal | DMM Disease Models and Mechanisms |
Volume | 16 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2023 |
Bibliographical note
Funding Information:This work was supported by research grants from the Stichting ParkinsonFonds (the Netherlands) to V.B. (110875) and W.M. (110825), and by Erasmus MC. Open Access funding provided by Stichting ParkinsonFonds. Deposited in PMC for immediate release.
Funding Information:
V.B. received research grants from the Stichting ParkinsonFonds (the Netherlands) and from Alzheimer Nederland. V.B. also received honoraria from Elsevier Ltd for serving as co-Editor-in-Chief of Parkinsonism & Related Disorders. The other authors declare no conflicts of interest or competing interests.
Publisher Copyright:
© 2023. Published by The Company of Biologists Ltd.